A pharmacokinetic binding model for bevacizumab and VEGF165 in colorectal cancer patients
Crossref DOI link: https://doi.org/10.1007/s00280-015-2701-3
Published Online: 2015-02-17
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Panoilia, Eirini
Schindler, Emilie
Samantas, Epaminontas
Aravantinos, Gerasimos
Kalofonos, Haralabos P.
Christodoulou, Christos
Patrinos, George P.
Friberg, Lena E.
Sivolapenko, Gregory
License valid from 2015-02-17